Why Eli Lilly Stock Just Popped

Eli Lilly (NYSE: LLY) stock bounced back 2.4% by 9:50 a.m. ET Monday after taking a tumble last week. Shares of the big pharma stock and manufacturer of Mounjaro and Zepbound GLP-1 weight loss drugs sank several percent Thursday after Hims & Hers Health (NYSE: HIMS) announced it would sell an Ozempic lookalike pill to compete with Novo Nordisk's (NYSE: NVO) Wegovy pill -- and with Eli Lilly's Mounjaro and Zepbound injectable weight loss drugs as well. Will AI create the world's first trillionaire? Our team ...